In vitro effects of beta-endorphin on testicular release of androgens in the lizard Podarcis sicula Raf.

The effects of the proopiomelanocortin-derived opioid peptide, beta-endorphin (beta-EP), and of the opioid antagonist, naloxone (NAL), on both basal and pituitary-stimulated androgen secretion from superfused quiescent and active testes were assessed in the adult lizard, Podarcis sicula. In the absence of the homologous pituitary, in vitro treatment with beta-EP and/or NAL did not affect basal secretion of androgens from quiescent and active testes. Conversely, in the presence of the homologous pituitary, treatment with beta-EP brought about a decrease in androgen secretion in active testes, but no effect on quiescent ones. Naloxone counteracted the inhibitor effect of beta-EP in active testes, and enhanced maximal pituitary-stimulated secretion of androgens in quiescent but not in active testes. The effects produces by beta-endorphin and naloxone were reversible. These results suggest that, in this lizard, opioids might be involved in the control of androgen release. The lack of effect of beta-EP and naloxone when added directly to the testes seems to suggest that the opioid agonist and antagonist act on androgen release by modulating pituitary gonadotrophin output.